Pathogenesis and prophylaxis of AMD: Focus on oxidative stress and antioxidants;Patogeneza i proflaktyka AMD: Rola stresu oksydacyjnego i antyoksydantów

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 333-343

  Wiktorowska Owczarek, Anna ^a   Nowak, Jerzy Z ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

AMD; Carotenoids; Glutathione; Lipofuscin; Oxidative stress; Prophylaxis; Retinal antooxidative defense systems; Vitamin C; Vitamin e

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RETINA; RETINA MACULA DEGENERATION; REVIEW;

ANTIOXIDANTS; HUMANS; MACULAR DEGENERATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINA;

EID: 78049433628     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Ahmed S. S., Lott M. N., Marcus D. M.: The macular xanthophylls. Surv. Ophthalmol., 2005;50:183-193 (Pubitemid 40340949)
2. Albanes D., Heinonen O. P., Taylor P. R., Virtamo J., Edwards B. K., Rautalahti M., Hartman A. M., Palmgren J., Freedman L. S., Haapakoski J., Barrett M. J., Pietinen P., Malila N., Tala E., Liippo K., Salomaa E. R., Tangrea J. A., Teppo L., Askin F. B., Taskinen E., Erozan Y., Greenwald P., Huttunen J. K.: α-tocopherol and β-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst., 1996;88:1560-1570 (Pubitemid 26374509)
3. Algvere P. V., Marshall J., Seregard S.: Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol. Scand., 2006, 84; 4-15 (Pubitemid 43337467)
4. Beatty S., Koh H., Phil M., Henson D., Boulton M.: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol., 2000;45:115-134
5. Bhosale P., Serban B., Bernstein PS.: Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium. Arch. Biochem. Biophys., 2009;483:175-181
6. Bilska A., Kryczyk A., Włodek L.: Różne oblicza biologicznej roli glutationu. Postepy Hig. Med. Dosw.: 2007;61:438-453
7. Bone R. A., Landrum J. T., Cao Y., Howard A. N., Alvarez-Calderon F.: Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr. Metab., 2007;4:12
8. Bone R. A., Landrum J. T., Fernandez L., Tarsis S. L.: Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest. Ophthalmol. Vis. Sci., 1988;29:843-849
9. Bone R. A., Landrum J. T., Hime G. W., Cains A., Zamor J.: Stereochemistry of the human macular carotenoids. Invest. Ophthalmol. Vis. Sci., 1993;34:2033-2040 (Pubitemid 23148640)
10. Bone R. A., Landrum J. T., Tarsis S. L.: Preliminary identification of the human macular pigment. Vision Res., 1985;25:1531-1535 (Pubitemid 16207358)
11. Boulton M., Rózanowska M., Rózanowski B., Wess T.: The photoreactivity of ocular lipofuscin. Photochem. Photobiol. Sci., 2004;3:759-764 (Pubitemid 39302976)
12. Catala A.: Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids, 2009;157:1-11
13. Chucair A. J., Rotstein N. P., SanGiovanni J. P., During A., Chew E. Y., Politi L. E.: Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Invest. Ophthalmol. Vis. Sci., 2007;48:5168-5177 (Pubitemid 351260928)
14. Dong L. M., Stark W. J., Jefferys J. L., Al-Hazzaa S., Bressler S. B., Solomon S. D., Bressler N. M.: Progression of age-related macular degeneration after cataract surgery. Arch. Ophthalmol., 2009;127:1412-1419
15. Drobek-Słowik M., Karczewicz D., Safranow K.: Potencjalny udział stresu oksydacyjnego w patogenezie zwyrodnienia plamki zwia̧zanego z wiekiem (AMD). Postepy Hig. Med. Dosw., 2007;61:28-37
16. El-Agamey A., Lowe G. M., McGarvey D. J., Mortensen A., Phillip D. M., Truscott T. G., Young A. J.: Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch. Biochem. Biophys., 2004;430:37-48 (Pubitemid 39119778)
17. Esterbauer H.: Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr., 1993;1993(Suppl. 5):779S-785S
18. Fessel J. P., Hulette C., Powell S., Roberts LJ. II, Zhang J.: Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease. J. Neurochem., 2003;85:645-650 (Pubitemid 36531927)
19. Gilca M., Stoian I., Atanasiu V., Virgolici B.: The oxidative hypothesis of senescence. J. Postgrad. Med., 2007;53:207-213 (Pubitemid 47281981)
20. Gruszecki W. I., Strzałka K.: Carotenoids as modulators of lipid membrane physical properties. Biochim. Biophys. Acta, 2005;1740:108-115 (Pubitemid 40798219)
21. Handelman G. J., Dratz E. A., Reay C. C., van Kuijk J. G.: Carotenoids in the human macula and whole retina. Invest. Ophthalmol. Vis. Sci., 1988, 29; 850-855
22. Jin G. F., Hurst J. S., Godley B. F.: Hydrogen peroxide stimulates apoptosis in cultured human retinal pigment epithelial cells. Curr. Eye Res., 2001, 22; 165-73 (Pubitemid 32881422)
23. Johnson E. J., Neuringer M., Russell R. M., Schalch W., Snodderly D. M.: Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest. Ophthalmol. Vis. Sci., 2005;46:692-702 (Pubitemid 40270354)
24. Junghans A., Sies H., Stahl W.: Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch. Biochem. Biophys., 2001;391:160-164 (Pubitemid 32662257)
25. Kim S. R., Nakanishi K., Itagaki Y., Sparrow J. R.: Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp. Eye Res., 2006;82; 828-839 (Pubitemid 43170883)
26. Krinsky N. I., Landrum J. T., Bone R. A.: Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu. Rev. Nutr., 2003;23:171-201 (Pubitemid 37059721)
27. Krohne T. U., Kaemmerer E., Holz P. G., Kopitz J.: Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action. Exp. Eye Res., 2010;90:261-266
28. Landrum J. T., Bone R. A.: Lutein, zeaxanthin, and the macular pigment. Arch. Biochem. Biophys., 2001;385:28-40 (Pubitemid 32988979)
29. Lawson J. A., Kim S., Powell W. S., FitzGerald G. A., Rokach J.: Oxidized derivatives of ω-3 fatty acids: identification of IPF3α-VI in human urine. J. Lipid Res., 2006;47:2515-2524 (Pubitemid 44936113)
30. Lawson J. A., Rokach J., FitzGerald G. A.: Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J. Biol. Chem., 1999;274:24441-24444
31. Liang F. Q., Godley B. F: Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp. Eye Res., 2003;76:397-403 (Pubitemid 36299052)
32. Medina S., Martinez M., Hernanz A.: Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine and beta-amyloid peptide 1-42. Free Radic. Res., 2002;36:1179-1184 (Pubitemid 35230238)
33. Nowak J. Z.: Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol. Rep., 2006, 58:353-363 (Pubitemid 44111070)
34. Nowak J. Z.: Druzy, złogi podstawne, proces zapalny i zwyrodnienie plamki zwia̧zane z wiekiem (AMD). Magazyn Okulistyczny, 2005;3:174-186
35. Nowak J. Z.: Przeciwzapalne "prowygaszeniowe" pochodne wielonienasyconych kwasów tłuszczowych omega-3 i omega-6. Postepy Hig. Med. Dosw., 2010;64:115-132
36. Nowak J. Z.: Rola lipofuscyny w etiopatogenezie zwyrodnienia plamki zwia̧zanego z wiekiem (AMD). Magazyn Okulistyczny, 2005;2:103-114
37. Nowak J. Z.: W poszukiwaniu biomarkerów dla zwyrodnienia plamki zwia̧zanego z wiekiem (AMD). Mag. Lek. Okul., 2009;3:132-143
38. Nowak J. Z.: Wielonienasycone kwasy tłuszczowe omega-3 w siatkówce i praktyce medycznej - blaskii cienie. Mag. Lek. Okul., 2009;3:208-220
39. Nowak J. Z.: Zwyrodnienie plamki zwia̧zane z wiekiem a układ odpornościowy: ile immunologii jest w AMD? Mag. Lek. Okul., 2009;3:102-114
40. Nowak J. Z., Wiktorowska-Owczarek A.: Neowaskularyzacja w tkankach oka: mechanizmy i rola czynników pro-i antyangiogennych. Klin. Oczna, 2004;106:90-97
41. Potargowicz E., Szerszenowicz E., Staniszewska M., Nowak D.: Mitochondria jako źródło reaktywnych form tlenu. Postepy Hig. Med. Dosw., 2005;59:259-266
42. Roberts J. E.: Ocular phototoxicity. J. Photochem. Photobiol. B., 2001, 64; 136-143
43. Roberts L. J. II, Montine T. J., Markesbery W. R., Tapper A. R., Hardy P., Chemtob S., Dettbarn W. D., Morrow J. D.: Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem., 1998;273:13605-13612 (Pubitemid 28268404)
44. Robman L., Vu H., Hodge A., Tikellis G., Dimitrov P., McCarty C., Guymer R.: Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can. J. Ophthalmol., 2007;42:720-726 (Pubitemid 350157561)
45. Shamsi F. A., Boulton M.: Inhibition of RPE lysosomal and antioxidant acivity by the age pigment lipofuscin. Invest. Ophthalmol. Vis. Sci., 2001;42:3041-3046 (Pubitemid 33035307)
46. Sies H., Stahl W., Sundquist A. R.: Antioxidant functions of vitamins. Vitamin E and C., beta-carotene, and other carotenoids. Ann. NY Acad. Sci., 1992;30:669
47. Sommerburg O. G., Siems W. G., Hurst J. S., Lewis J. W., Kliger D. S., van Kuijk F. J.: Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr. Eye Res., 1999;19:491-495 (Pubitemid 30052875)
48. Song W. L., Lawson J. A., Reilly D., Rokach J., Chang C. T., Giasson B., FitzGerald G. A.: Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid. J. Biol. Chem., 2008;283:6-16
49. Song W. L., Paschos G., Fries S., Reilly M. P., Yu Y., Rokach J., Chang C. T., Patel P., Lawson J. A., Fitzgerald G. A.: Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation. J. Biol. Chem., 2009;284:23636-23643
50. Sparrow J. R.: Therapy for macular degeneration: insight from acne. Proc. Natl. Acad. Sci. USA, 2003;100:4353-4354 (Pubitemid 36457729)
51. Sparrow J. R., Cai B.: Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest. Ophthalmol. Vis. Sci., 2001;42:1356-1362 (Pubitemid 32381981)
52. Sparrow J. R., Nakanishi K., Parish C. A.: The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci., 2000;41:1981-1989 (Pubitemid 30354376)
53. Thurnham D. I.: Macular zeaxanthins and lutein - a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease. Nutr. Res. Rev., 2007;20:163-179 (Pubitemid 350197965)
54. Thurnham D. I., Tremel A., Howard A. N.: A supplementation study in human subjects with a combination of meso-zeaxanthin, (3R, 3'R) - zeaxanthin and (3R, 3'R, 6'R)-lutein. Br. J. Nutr., 2008;100:1307-1314
55. van Leeuwen R., Boekhoorn S., Vingerling J. R., Witteman J. C., Klaver C. C., Hofman A., de Jong P. T.: Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA, 2005;294:3101-3107 (Pubitemid 43016801)
56. Wiktorowska-Owczarek A., Nowak J. Z.: AMD a stres oksydacyjny. 1. Analiza czynników wpływaja̧cych na powstawanie wolnych rodników tlenowych w siatkówce. 2. Analiza składnikó w preparatów farmaceutycznychstosowanych w profilaktyce AMD. Mag. Lek. Okul., 2008;3:200-212
57. Wiktorowska-Owczarek A., Nowak J. Z.: Glutation - endogenny tripeptyd o właściwościach przeciwutleniaja̧cych: implikacje okulistyczne. Magazyn Okulistyczny, 2006;3:152-159
58. Wiktorowska-Owczarek A., Nowak J. Z.: Luteina i zeaksantyna - dwa karotenoidy pełnia̧ce ochronna̧ funkcjȩ w zwyrodnieniu plamki zwia̧zanym z wiekiem. Okulistyka, 2004;4:29-34
59. Wiktorowska-Owczarek A., Nowak J. Z.: Oxidative damage in age-related macular degeneration (AMD) and antioxidant protection as a therapeutic strategy. Polish J. Environ. Stud., 2006;15:69-72
60. Winiarska K.: Glutation: niezwykłe funkcje pospolitego tripeptydu. Postepy Biochem., 2000;46:318-326
61. Winkler B. S., Orselli S. M., Rex T. S.: The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. Free Radic. Biol. Med., 1994;17:333-349 (Pubitemid 24296153)
62. Wrona M., Różanowska M., Sarna T.: Zeaxanthin in combination with ascorbic acid or α-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids. Free Radic. Biol. Med., 2004;36:1094-1101 (Pubitemid 38479863)